| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| lucatumumab | tumor necrosis factor receptor superfamily member 5 | biotech | NA | drugbank , DGIDB | leukemia[MeSHID:D007938] Lymphoma[MeSHID:D008223] Lymph[MeSHID:D008196] Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.89 | investigational | unknown |
| lucatumumab | tnf related activation protein | NA | Clinical trial target | TTD , DGIDB | leukemia[MeSHID:D007938] Lymphoma[MeSHID:D008223] Lymph[MeSHID:D008196] Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
5.79 | phase 2 | unknown |
| click here to return to the previous page | ||||||||